Literature DB >> 19293540

Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis.

Mehmet Derya Demirag1, Seminur Haznedaroglu, Banu Sancak, Ceyla Konca, Ozlem Gulbahar, M Akif Ozturk, Berna Goker.   

Abstract

OBJECTIVE: To investigate the role of circulating hepcidin, which is a homeostatic regulator of iron metabolism and a mediator of inflammation, in anemia associated with rheumatoid arthritis.
METHODS: Forty patients with rheumatoid arthritis (19 with anemia and 21 without anemia), 12 patients with iron deficiency anemia and 14 healthy adults were studied. Serum hepcidin levels were analyzed with hepcidin prohormone solid phase enzyme-linked immunosorbent assay.
RESULTS: The mean serum hepcidin levels were significantly higher in patients with rheumatoid arthritis with anemia compared to healthy adults and those with iron deficiency anemia. The active rheumatoid arthritis group had significantly higher mean serum hepcidin levels than the inactive rheumatoid arthritis group. In the rheumatoid arthritis group, serum hepcidin levels were positively correlated with disease activity, but inversely correlated with hemoglobin levels. The serum hepcidin level was found to be a significant predictor for hemoglobin level.
CONCLUSION: Serum hepcidin levels are closely associated with disease activity in rheumatoid arthritis patients and might play a role in the pathobiology of chronic disease anemia associated with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293540     DOI: 10.2169/internalmedicine.48.1578

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  24 in total

1.  Intravenous iron therapy is the option for RA patient with absolute iron deficiency accompanied with functional iron deficiency.

Authors:  Jing Tan; Jing Wei
Journal:  Clin Rheumatol       Date:  2012-05-31       Impact factor: 2.980

Review 2.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

3.  Effects of intravenous iron saccharate on improving severe anemia in rheumatoid arthritis patients.

Authors:  Wei-Sheng Chen; Chun-Yu Liu; Hui-Ting Lee; Kelvin Tsai; Yi-Chun Lin; Der-Cherng Tarng; Chao-Hung Ho; Hsiao-Yi Lin
Journal:  Clin Rheumatol       Date:  2011-10-29       Impact factor: 2.980

4.  Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo; Ya-Ling Yang; Jiin-Haur Chuang; Mao-Meng Tiao; Hong-Ren Yu; Li-Tung Huang; Kuender D Yang; Wei-Chiao Chang; Chiu-Ping Lee; Ying-Hsien Huang
Journal:  J Clin Immunol       Date:  2012-03-06       Impact factor: 8.317

5.  The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.

Authors:  Daniel E Furst; Jonathan Kay; Mary Chester Wasko; Edward Keystone; Arthur Kavanaugh; Atul Deodhar; Frederick T Murphy; Jeanette H Magnus; Elizabeth C Hsia; Benjamin Hsu; Stephen Xu; Mahboob U Rahman; Mittie K Doyle
Journal:  Rheumatology (Oxford)       Date:  2013-07-09       Impact factor: 7.580

Review 6.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

7.  Erythroferrone Expression in Anemic Rheumatoid Arthritis Patients: Is It Disordered Iron Trafficking or Disease Activity?

Authors:  Soha R Youssef; Esraa H Hassan; Caroline S Morad; Adel A Elazab Elged; Rasha A El-Gamal
Journal:  J Inflamm Res       Date:  2021-09-07

Review 8.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  [Anemia in patients with rheumatoid arthritis].

Authors:  M Wahle
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

10.  Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients.

Authors:  Soken-Nakazawa J Song; Mitsuhiro Iwahashi; Naohisa Tomosugi; Kazuko Uno; Jiro Yamana; Seizou Yamana; Tomoyasu Isobe; Hiroki Ito; Hiroshi Kawabata; Kazuyuki Yoshizaki
Journal:  Arthritis Res Ther       Date:  2013-10-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.